Document Detail


Matrix engineering.
MedLine Citation:
PMID:  1772987     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Matrix engineering is a technology that utilizes hyaluronan (HA, hyaluronic acid) based matrices to control, direct or augment tissue regenerative processes. Hyaluronan and the concept of matrix engineering have become established tools in ophthalmic and orthopaedic medicine. The clinical indications for HA are limited by the physical properties and short residence time of the natural HA molecule. To expand and improve upon its current medical applications, a family of HA derivatives was prepared by chemical modification and cross-linking. Relative to the non-modified HA molecule, the hylan family of polymers provides more versatile physical forms, improved mechanical properties and an extended residence time. Hylan can also be used as a surface coating to improve blood compatibility. The chemical, physical and biological properties of hylans will be reviewed, focusing on the specific therapeutic indications they enable.
Authors:
E A Balazs; P A Bland; J L Denlinger; A I Goldman; N E Larsen; E A Leshchiner; A Leshchiner; B Morales
Related Documents :
23886787 - Protein and polysaccharide-composite sol-gel silicate film for an interference-free amp...
18317747 - Photocatalytic antimicrobial activity of thin surface films of tio(2), cuo and tio (2)/...
20816957 - Vancomycin release from poly(d,l-lactic acid) spray-coated hydroxyapatite fibers.
15020107 - Fluor-hydroxyapatite sol-gel coating on titanium substrate for hard tissue implants.
6690447 - The composition of normal and osteoarthritic articular cartilage from human knee joints...
18309217 - Impact of polymer-sludge interaction on rheogram peaks and optimum dose determination.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis     Volume:  2     ISSN:  0957-5235     ISO Abbreviation:  Blood Coagul. Fibrinolysis     Publication Date:  1991 Feb 
Date Detail:
Created Date:  1992-03-04     Completed Date:  1992-03-04     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  9102551     Medline TA:  Blood Coagul Fibrinolysis     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  173-8     Citation Subset:  IM    
Affiliation:
Biomatrix Inc, Ridgefield, NJ 07657.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Elasticity
Embolization, Therapeutic
Extracellular Matrix*
Gels
Guinea Pigs
Humans
Hyaluronic Acid / analogs & derivatives,  therapeutic use*
Joints / surgery*
Leeches / physiology
Mice
Ophthalmologic Surgical Procedures*
Prostheses and Implants*
Solubility
Solutions
Synovial Fluid
Tissue Expansion Devices
Viscosity
Vitreous Body / surgery
Chemical
Reg. No./Substance:
0/Gels; 0/Solutions; 125935-84-4/hylan; 9004-61-9/Hyaluronic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  5-Hydroxytryptamine (5-HT)-induced shape change in human platelets determined by computerized data a...
Next Document:  Calin--a platelet adhesion inhibitor from the saliva of the medicinal leech.